(4R,5S)-5-(3,5-bis(trifluoroMethyl)phenyl)-4-Methyloxazolidin-2-one

We are (4R,5S)-5-(3,5-bis(trifluoroMethyl)phenyl)-4-Methyloxazolidin-2-one CAS:875444-08-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(4R,5S)-5-(3,5-bis(trifluoroMethyl)phenyl)-4-Methyloxazolidin-2-one
CAS.NO: 875444-08-9
Synonyms:
(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyl-1,3-oxazolidin-2-one
2-Oxazolidinone, 5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-, (4S,5R)-
2-Oxazolidinone,5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-,(4S,5R)
(4S,5R)-5-(3,5-bis-trifluoromethyl-phenyl)-4-methyl-oxazolidin-2-one
(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one
(4R,5S)-5-(3,5-bis(trifluoroMethyl)phenyl)-4-Methyloxazolidin-2-one

Molecular Formula:C12H9F6NO2
Molecular Weight: 313.196

Physical and Chemical Properties:
Density: 1.4±0.1 g/cm3
Boiling point: 329.5±42.0 °C at 760 mmHg
Melting point: /
Flash point:153.1±27.9 °C
Refractive index: 1.433

Specification:
Appearance: White to yellow powder
Purity:≥98%
Water:<5000ppm
Loss on drying:<1000ppm

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Anacetrapib CAS:875446-37-0

Related News: Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.66981-73-5 The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.4415-73-0 Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.2-fluoro-3-metil-5-nitropiridina CAS:19346-46-4 Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.